NEW YORK (GenomeWeb) – KeyGene and Floragenex today said they have extended a licensing agreement covering KeyGene's sequence-based genotyping technology.
As part of the deal, Floragenex, a genomics service provider, will extend its SBG service offerings to include double digest RAD-Seq in non-commercial and academic research across all species. Financial and other terms were not disclosed.
In late 2012, the companies settled a patent dispute and reached a licensing agreement that allowed Portland, Oregon-based Floragenex to continue applying its Restriction-site Associated DNA method in certain fields.
"Floragenex's expertise, professionalism, and impressive track record with RAD-Seq across a wide range of genomes logically fit with a broader portfolio of SBG service offerings," KeyGene CSO Michiel van Eijk said in a statement. "This will accelerate the understanding of genetic variation in plants, animals, and other organisms in a highly cost-efficient manner."